XML 68 R50.htm IDEA: XBRL DOCUMENT
v3.22.4

Acquisition - Preliminary Fair Value of Intangible Assets (Details) - USD ($) $ in Thousands |  | 12 Months Ended |
--- | --- | --- | ---
Oct. 01, 2020 | Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | Jul. 31, 2022
Acquisitions |  |  |  |  |
Estimated Fair Value |  |  |  |  | $ 1,000
Amortization Expense |  | $ 15,100 | $ 14,400 | $ 6,600 |
CRYOPDP |  |  |  |  |
Acquisitions |  |  |  |  |
Estimated Fair Value | $ 28,235 |  |  |  |
Amortization Expense | 3,077 |  |  |  |
CRYOPDP | Software |  |  |  |  |
Acquisitions |  |  |  |  |
Estimated Fair Value | $ 3,578 |  |  |  |
Estimated Useful Life | 7 years |  |  |  |
Amortization Expense | $ 511 |  |  |  |
CRYOPDP | Customer relationships |  |  |  |  |
Acquisitions |  |  |  |  |
Estimated Fair Value | $ 5,871 |  |  |  |
Estimated Useful Life | 11 years 6 months |  |  |  |
Amortization Expense | $ 511 |  |  |  |
CRYOPDP | Agent network |  |  |  |  |
Acquisitions |  |  |  |  |
Estimated Fair Value | $ 8,219 |  |  |  |
Estimated Useful Life | 4 years |  |  |  |
Amortization Expense | $ 2,055 |  |  |  |
CRYOPDP | Trade name/trademarks |  |  |  |  |
Acquisitions |  |  |  |  |
Estimated Fair Value | 10,567 |  |  |  |
MVE |  |  |  |  |
Acquisitions |  |  |  |  |
Estimated Fair Value | 184,991 |  |  |  |
Amortization Expense | 10,634 |  |  |  |
MVE | Customer relationships |  |  |  |  |
Acquisitions |  |  |  |  |
Estimated Fair Value | 118,600 |  |  |  |
Amortization Expense | $ 8,179 |  |  |  |
MVE | Customer relationships | Global Bioservices |  |  |  |  |
Acquisitions |  |  |  |  |
Estimated Useful Life | 14 years 6 months |  |  |  |
MVE | Trade name/trademarks |  |  |  |  |
Acquisitions |  |  |  |  |
Estimated Fair Value | $ 32,800 |  |  |  |
MVE | Order backlog |  |  |  |  |
Acquisitions |  |  |  |  |
Estimated Fair Value | $ 2,600 |  |  |  |
MVE | Order backlog | Global Bioservices |  |  |  |  |
Acquisitions |  |  |  |  |
Estimated Useful Life | 1 month 15 days |  |  |  |
MVE | Developed technology |  |  |  |  |
Acquisitions |  |  |  |  |
Estimated Fair Value | $ 28,700 |  |  |  |
Amortization Expense | $ 2,392 |  |  |  |
MVE | Developed technology | Global Bioservices |  |  |  |  |
Acquisitions |  |  |  |  |
Estimated Useful Life | 12 years |  |  |  |
MVE | Land use rights |  |  |  |  |
Acquisitions |  |  |  |  |
Estimated Fair Value | $ 2,291 |  |  |  |
Amortization Expense | $ 63 |  |  |  |
MVE | Land use rights | Global Bioservices |  |  |  |  |
Acquisitions |  |  |  |  |
Estimated Useful Life | 38 years |  |  |  |

X
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a)(3) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275 + Details
Name: | us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -URI https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 45 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274 + Details
Name: | us-gaap_AmortizationOfIntangibleAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_BusinessAcquisitionLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of intangible assets, excluding goodwill, acquired at the acquisition date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472 + Details
Name: | us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=cyrx_CryopdpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_ComputerSoftwareIntangibleAssetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cyrx_AgentNetworkMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=cyrx_MveCryobiologicalStorageBusinessMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=cyrx_GlobalBioservicesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OrderOrProductionBacklogMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_UseRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |